KODIAK SCIENCES INC. Other Non-Current Liabilities
KODIAK SCIENCES INC. (KOD) had Other Non-Current Liabilities of $0 as of 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Balance Sheet › Liabilities, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2024-03-28
- 2023-12-31: Other Liabilities, Noncurrent $0.00.
- 2023-09-30: Other Liabilities, Noncurrent $0.00.
- 2023-06-30: Other Liabilities, Noncurrent $0.00.
- 2023-03-31: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $162.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $175.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $187.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $199.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $211.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $223.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $234.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $245.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $256.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $267.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $276.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $288.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $295.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $308.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $317.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $327.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $530.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $552.00K 10-Q · filed 2018-11-16 |
| 2017-12-31 | $586.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |